These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2643864)

  • 1. Effects of prazosin and labetalol on blood pressure control and blood lipid levels in patients with mild-to-moderate essential hypertension.
    Farry JP; Fischl SJ; Tighe MJ; Krell MJ
    Am J Med; 1989 Jan; 86(1B):41-4. PubMed ID: 2643864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of labetalol and prazosin in hypertensive patients using automated ambulatory monitoring.
    Gray JM; Silberman HM; Gorwit JI
    Am J Med; 1988 May; 84(5):904-10. PubMed ID: 3284341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of labetalol and prazosin on exercise haemodynamics in hypertensive patients.
    Feit A; Cohen M; Dimino L; el-Sherif N; Holtzman R; Venkata C; Ram S; Gaffeny D; Heller J; Kaplan N
    J Hum Hypertens; 1991 Feb; 5(1):39-43. PubMed ID: 2041034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prazosin on blood pressure and diabetic control in patients with type II diabetes mellitus and mild essential hypertension.
    Levy P
    Am J Med; 1989 Jan; 86(1B):59-62. PubMed ID: 2913774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the combination of alpha- and beta-adrenoceptor blockade in hypertension.
    Stokes GS; Mennie BA; Gellatly R; Hill A
    Clin Pharmacol Ther; 1983 Nov; 34(5):576-82. PubMed ID: 6627819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study on the effect of atenolol and labetalol on exercise capacity and lipid serum levels in essential hypertension.
    Schamaun O; Westheim A; Qvigstad EK; Teisberg P
    Nephron; 1987; 47 Suppl 1():135-7. PubMed ID: 3320787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alpha- and beta-adrenergic antagonists on plasma apolipoproteins and forearm blood flow in patients with mild hypertension.
    Sacks FM; Creager MA; Gallagher SJ; Loscalzo J; Dzau VJ
    Am J Med; 1989 Jan; 86(1B):8-13. PubMed ID: 2563311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension.
    Frishman WH; Michelson EL; Johnson BF; Poland MP
    Am J Med; 1983 Oct; 75(4A):54-67. PubMed ID: 6356900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antihypertensive therapy on blood pressure control, cognition, and reactivity. A placebo-controlled comparison of prazosin, propranolol, and hydrochlorothiazide.
    Lasser NL; Nash J; Lasser VI; Hamill SJ; Batey DM
    Am J Med; 1989 Jan; 86(1B):98-103. PubMed ID: 2913779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of terazosin and methyclothiazide on blood pressure and serum lipids.
    Luther RR; Glassman HN; Estep CB; Maurath CJ; Jordan DC
    Am Heart J; 1989 Apr; 117(4):842-7. PubMed ID: 2564723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of alpha- and beta-blocker antihypertensive therapy on blood lipids: a multicenter trial.
    Goto Y
    Am J Med; 1984 Feb; 76(2A):72-8. PubMed ID: 6142645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results obtained from labetalol therapy in essential hypertension.
    Cagatay G; Soydan I
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):110-2. PubMed ID: 3557731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect on lipids, lipoproteins and apoproteins of labetalol prescribed in doses of 400 mg/day in hypertensive patients. Double-blind versus placebo study].
    Rouffy J; Bakir R; Chanu B; Djian F; Goy-Loeper J; Henry Amar M; Renon D; Pappo M
    Pathol Biol (Paris); 1986 Apr; 34(4):253-8. PubMed ID: 3529000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prazosin versus hydrochlorothiazide as initial antihypertensive therapy in black versus white patients.
    Batey DM; Nicolich MJ; Lasser VI; Jeffrey SS; Lasser NL
    Am J Med; 1989 Jan; 86(1B):74-8. PubMed ID: 2643866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of prazosin and propranolol on blood lipids and lipoproteins in hypertensive patients.
    Velasco M; Hurt E; Silva H; Urbina-Quintana A; Hernández-Pieretti O; Feldstein E; Camejo G
    Am J Med; 1986 Feb; 80(2A):109-13. PubMed ID: 3080882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of labetalol and prazosin combined with atenolol in non-responders to atenolol plus hydrochlorothiazide in uncomplicated hypertension.
    van der Veur E; ten Berge BS; Donker AJ; May JF; Schuurman FH; Wesseling H
    Eur J Clin Pharmacol; 1985; 28(5):507-11. PubMed ID: 3899671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of prazosin and propranolol on blood lipid profiles in hypertensive, hypercholesterolemic patients. Preliminary results.
    Leon AS; Hunninghake DB; Belcher J; Stoulil J
    Am J Med; 1989 Jan; 86(1B):36-40. PubMed ID: 2913770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.
    Talseth T; Westlie L; Daae L; Vatle S
    Am Heart J; 1988 Dec; 116(6 Pt 2):1790-6. PubMed ID: 2904752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forearm and finger hemodynamics, blood pressure control, and lipid changes in patients with diabetic hypertension treated with atenolol and prazosin.
    Kwan CM; Shepherd AM; Johnson J; Taylor WF
    Clin Pharmacol Ther; 1988 Aug; 44(2):202-10. PubMed ID: 3293875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy of prazosin versus propranolol as initial antihypertensive therapy.
    Alderman MH
    Am J Med; 1989 Jan; 86(1B):45-9. PubMed ID: 2643865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.